SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Nov 29
 -0.74 / -1.57%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").

No recent news for SPDR® S&P Pharmaceuticals ETF.


1 month-1.63% 3 years+4.07%
3 months-2.54% 5 years+3.66%
1 year-0.97% Since inception+9.26%
Data through 11/27/2021

Quote Details

Previous close$47.09
Open day’s range46.35 – 47.25
Net asset value (NAV)47.11 (11/26/2021)
Daily volume42,255
Average volume (3 months)55,222
Data as of 4:00pm ET, 11/29/2021

Peer Comparisonvs. Health ETFs

Performance 5-yr return+3.66%+13.75%
Expense Gross exp ratio0.35%1.00%
Risk 5 year sharpe ratio0.260.91
Net assets$232.5M$2.4B
Average market cap$11.7B$37.7B
Average P/E17.325.0
Dividend / Share--0.29%


RYH Invesco S&P 500® Equal Weight Health Ca...
VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
MRK Merck5.36%
OGN Organon & Co4.85%
LLY Eli Lilly and Co4.75%
ZTS Zoetis Inc4.67%
PRGO Perrigo Company PLC4.62%
RPRX Royalty Pharma PLC4.59%
CTLT Catalent Inc4.47%
JAZZ Jazz Pharmaceuticals PLC4.42%
ELAN Elanco Animal Health Inc4.40%
JNJ Johnson & Johnson4.36%